NCT04654143View on ClinicalTrials.gov

Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BVL-GSK098 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 2, 2020

Primary Completion Date

May 30, 2022

Study Completion Date

January 16, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

BVL-GSK098 capsule, placebo

Oral QD

Trial Locations (2)

28006

Hospital Universitario de La Princesa, Madrid

08041

CIM Sant Pau, Barcelona

Sponsors

Lead Sponsor

BioVersys AG
All Listed Sponsors
lead

BioVersys AG

INDUSTRY

NCT04654143 - Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BVL-GSK098 in Healthy Volunteers | Biotech Hunter | Biotech Hunter